A Study of Pirfenidone in Patients with Unclassifiable Progressive Fibrosing Interstitial Lung Disease

Update Il y a 4 ans
Reference: EUCTR2016-002744-17

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

•To evaluate the effect of pirfenidone versus (vs.) placebo on lung function parameters


Inclusion criteria

  • Fibrosing interstitial lung disease (ILD) of unknown origin

Links